Inogen, Inc. (INGN) News
Follow Inogen, Inc. (INGN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Inogen Q3 Revenue Falls on Lower International Sales
EQUITY | Nov 05, 2026, 09:46 PM UTC
M
Inogen Q3 Revenue Falls 2.4% to $77.2M, Sets 2026 Outlook
Q3 2026 revenue was $77.2 million, down 2.4% from $79.1 million a year earlier. Inogen expects 2026 continuing-operations revenue of $298 million to $301 million and an adjusted loss of $7 million to $8 million.
EQUITY | Nov 05, 2026, 09:07 PM UTC
M
Inogen Announces Third-Quarter 2026 Financial Results
Inogen announced results for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:07 PM UTC
M
Inogen Cuts 2026 Revenue Guidance, Raises Adjusted EBITDA Outlook
Inogen reported second-quarter revenue of $95.1 million, up 3% year over year, and adjusted EBITDA of $2.4 million, up 15%. The company lowered full-year 2026 revenue guidance to $355-$361 million and raised adjusted EBI
EQUITY | Oct 13, 2026, 08:46 AM UTC
L
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (NASDAQ: INGN ) lowers FY2026 sales outlook from $366.000 million-$373.000 million to $355.000 million-$361.000 million vs $369.267 million estimate.
EARNINGS | Aug 06, 2026, 08:19 PM UTC
L
Inogen Appoints Andy Reding As COO, Effective On July 6, 2026
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Andy Reding to the newly created role of Chief Opera
EARNINGS | Jul 01, 2026, 08:08 PM UTC